Page last updated: 2024-11-08

1,3-cyclooctadiene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID299882
MeSH IDM0367701

Synonyms (36)

Synonym
nsc 105773
nsc 72422
ai3-26696
einecs 216-929-1
1,3-cyclooctadiene, (z,z)-
cis,cis-1,3-cyclooctadiene
nsc72422
nsc-72422
1,3-cyclooctadiene ,
nsc-105773
1700-10-3
nsc105773
(1z,3z)-cycloocta-1,3-diene
inchi=1/c8h12/c1-2-4-6-8-7-5-3-1/h1-4h,5-8h2/b3-1-,4-2
1,3-cyclooctadiene, (1z,3z)-
cis,cis-1,3-cyclooctadiene, 98%
cyclooctadiene
1,3-cyclooctadiene, technical, >=95% (gc)
cycloocta-1,3-diene
(1z,3e)-cycloocta-1,3-diene
cyclooctadienes
cyclooctadienes [un2520] [flammable liquid]
un2520
29965-97-7
3806-59-5
AKOS025295254
RRKODOZNUZCUBN-CCAGOZQPSA-N
RRKODOZNUZCUBN-PBIXIIOPSA-N
mfcd00001751
J-010594
1.3-cyclooctadiene
DTXSID30865523
Q56683052
EN300-6489763
AS-75607
EN300-179757
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.51 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]